Accordingly, as determined by KM-plotter, higher miR-575 expression levels were related to a significantly poorer prognosis than lower miR-575 levels in ER+ breast cancer patients receiving tamoxifen therapy (Figure 7H). This evidence concerns the gene ESR1 and breast cancer.